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ABSTRACT. Biodegradable stents are attracting the attention of many researchers in biomedical and materials 
research fields since they can absolve their specific function for the expected period of time and then gradually 
disappear. This feature allows avoiding the risk of long-term complications such as restenosis or mechanical 
instability of the device when the vessel grows in size in pediatric patients. Up to now biodegradable stents 
made of polymers or magnesium alloys have been proposed. However, both the solutions have limitations. The 
polymers have low mechanical properties, which lead to devices that cannot withstand the natural contraction 
of the blood vessel: the restenosis appears just after the implant, and can be ascribed to the compliance of the 
stent. The magnesium alloys have much higher mechanical properties, but they dissolve too fast in the human 
body. In this work we present some results of an ongoing study aiming to the development of biodegradable 
stents made of a magnesium alloy that is coated with a polymer having a high corrosion resistance. The 
mechanical action on the blood vessel is given by the magnesium stent for the desired period, being the stent 
protected against fast corrosion by the coating. The coating will dissolve in a longer term, thus delaying the 
exposition of the magnesium stent to the corrosive environment. We dealt with the problem exploiting the 
potentialities of a combined approach of experimental and computational methods (both standard and ad-hoc 
developed) for designing magnesium alloy, coating and scaffold geometry from different points of views. 
Our study required the following steps: i) selection of a Mg alloy suitable for stent production, having sufficient 
strength and elongation capability; ii) computational optimization of the stent geometry to minimize stress and 
strain after stent deployment, improve scaffolding ability and corrosion resistance; iii) development of a 
numerical model for studying stent degradation to support the selection of the best geometry; iv) optimization 
of the alloy microstructure and production of Mg alloy tubes for stent manufacturing; v) set up, in terms of laser 
cut and surface finishing, of the procedure to manufacture magnesium stents; vi) selection of a coating able to 
assure enough corrosion resistance and computational evaluation of the coating adhesion. 
In the paper the multi-disciplinary approach used to go through the steps above is summarized. The obtained 
results suggest that developed methodology is effective at designing innovative biomedical devices. 
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INTRODUCTION  
 
n the last years stent implantations (weather coronary stent or not) have steadily grown both in terms of number and 
of variety of implantations (type of blood vessels involved). As a consequence, a reduction in the number of surgical 
operations, which are more invasive for the patient (as, for example, the coronary by-pass surgery), was observed. 
As known, a bare metal stent (BMS) is a metallic mesh (obtained by laser cutting of a tube made of stainless steel, titanium 
or cobalt alloy) that is designed to expand a stenotic blood vessel (that is a vessel clogged by atherosclerotic plaque), thus 
enhancing the blood flux in the downstream vessel.  
During the implant the stent is fixed on the ending part of a catheter, which consists of an "inflatable balloon". The 
catheter is inserted in an artery through a skin cut. Once in position the balloon is inflated with a consequent dilatation of 
the stent, which exerts a radial force on the stenotic blood vessel. Then, the balloon is deflated and the catheter extracted: 
due to the permanent deformation, the stent remains in place and withstands the natural contraction of the blood vessel. 
Once in the vessel, the stent is enveloped by a new tissue, called neointima. It has been observed that in some cases the 
neointima proliferates in an uncontrolled way (hyperplasia) and tends to re-obstruct the vessel, thus vanishing the effect of 
the implantation.  
To avoid the neointimal proliferation, drug eluting stents (DES) have been introduced in the clinical practice from the 
beginning of 21st Century. They are metallic stent coated by a polymer which locally releases an anti-inflammatory drug. 
Recent studies claimed that in some cases DES may lead to the generation of thrombi after a long period (late stent 
thrombosis), which are extremely dangerous for the patient [1,2]. Moreover, they prevent late vessel adaptive or expansive 
remodeling, and hinder surgical re-vascularization. 
For this reason, starting from the clinical consideration that vessel scaffolding is only required transiently [3], a new 
generation of stents is under study [4]. It consists of bioresorbable scaffolds (BRS): the stent should remain in the body 
for the time required to support the vessel tissues, then it "vanishes" as it is dissolved in the human body. In this way the 
development of inflammatory phenomena (the reason for the hyperplasia of the neointima) is largely reduced, therefore 
avoiding the risk of restenosis. Moreover, thanks to the fairly long lasting mechanical action, the blood vessel is remodeled 
and remains opened also after the stent is fully dissolved. Moreover, the vessel can recover the natural vasomotor 
response, reintervention is facilitated, the dual anti-platelet therapy is shorter, the risk of strut fracture-induced restenosis 
is reduced and mechanical instability of the device when the vessel grows in size in pediatric patients is avoided. 
From the side of bioresorbable materials, they are required to be biocompatible, degradable at an appropriate rate, easy to 
manipulate, sterilisable and storable. From the side of bioresorbable scaffolds, different properties are required 
corresponding to the different phases of the vessel treatments. In the first phase of artery revascularization, BRS have to 
mimic DES, so they have to show good deliverability, flexibility, ductility, minimum recoil, high acute radial strength. In 
the second phase of restoration of the vessel natural vasomotor response, they have to perform the transition from active 
support to passive implant, showing structural discontinuity and radial strength loss. In the last phase of resorption, the 
passive implant has to benignly disappear. 
Up to now biodegradable stents made of polymers or magnesium or iron alloys have been proposed [5,6]. However, all 
the solutions have some limitations. The polymers have low mechanical properties, which lead to devices that cannot 
withstand the natural contraction of the blood vessel: the restenosis appears just after the implant, and can be ascribed to 
the compliance of the stent. The magnesium alloys have much higher mechanical properties than polymers. 
Unfortunately, they dissolve too fast in the human body: the duration in a blood vessel is about few weeks and not 6-10 
months, as should be to withstand the vessel remodeling. Lastly, the iron alloys degrade too slowly [7,8].  
In this work we present some results of an ongoing study aimed at the development of a hybrid bioresorbable stent (HBS) 
made of a magnesium alloy that is coated with a polymer having a high corrosion resistance. The mechanical action on the 
blood vessel is given by the magnesium stent for the desired period, being the stent protected against early onset of 
corrosion by the coating. The coating will dissolve in a longer term, thus delaying the exposition of the magnesium stent 
to the corrosive environment. 
We dealt with the problem exploiting the potentialities of a combined approach of experimental and computational 
methods (both standard and ad-hoc developed) for designing magnesium alloy, coating and scaffold geometry from 
I  
L. Petrini et alii, Frattura ed Integrità Strutturale, 29 (2014) 364-375; DOI: 10.3221/IGF-ESIS.29.32                                                                    
 
366 
 
different points of views, i.e mechanical properties, corrosion, manufacturability and biocompatibility, as summarized in 
Fig. 1. 
 
 
 
Figure 1: Scheme of the multidisciplinary approach used to develop a hybrid bioresorbable stent, made of a magnesium alloy coated 
with a polymer. 
 
Up to now we performed the following steps: i) selection of a Mg alloy suitable for stent production; ii) computational 
optimization of the stent geometry and experimental validation; iii) development of a numerical model for studying stent 
degradation to support the selection of the best geometry; iv) optimization of the alloy microstructure and production of 
Mg alloy tubes for stent manufacturing; v) set up, in terms of laser cut and surface finishing, of the procedure to 
manufacture magnesium stents; vi) selection of a coating able to assure enough corrosion resistance and computational 
evaluation of the coating adhesion. 
In the following sections, the above steps will be briefly summarized. 
 
 
SELECTION OF THE ALLOY 
 
 set of commercially available wrought Mg alloys were initially investigated. The AZ31, AZ61, AZ80, ZM21, 
ZK61 and WE43 alloys were considered in the form of extruded bars with a diameter of 15 mm. Specimens for 
tensile tests were machined from the bars with a gauge length of 40 mm and a diameter of 8 mm. Tests were 
performed at room temperature with an engineering strain rate of 1.3•10-3 s-1. Fig. 2 (left) depicts the tensile curves of 
the materials. All the alloys have a limited ductility if compared with stainless steels and Cr-Co alloys commonly used for 
stent production. This corresponds to a potential risk of fracture during crimping and expansion of the stent. The ZM21, 
AZ31 and AZ61 alloys shows the highest elongation to fracture values.  
Preliminary in vitro weight loss tests were also conducted on five of the alloys (AZ31, AZ61, AZ80, ZK60 and ZM21). 
Cylindrical specimens (height 5 mm, diameter 10 mm for ZK60 and 14 mm for the other alloys) were polished down to 
600 grit, rinsed in distilled water, degreased ultrasonically with anhydrous ethanol for 5 min and dried with warm air. The 
samples were immersed in a solution simulating plasma (Kokubo-c-SBF at 37 ◦C [9]), changed every 24 h to prevent 
saturation and to keep the pH to acceptable values (pH = 7.4). The surface area/solution volume ratio was 0.2 cm−1. 
The results plotted in Fig. 2 (right) show the best behaviour of the AZ series alloys over the ZM and ZK materials. 
Considering that a high percentage of aluminum may induce biocompatibility problems, AZ31 and ZM21 were selected as 
potential candidates for HBS and used in the following steps of stent development. 
 
 
OPTIMIZATION OF THE SCAFFOLD GEOMETRY 
 
onsidering the limited ductility of the selected alloys, a shape optimization method for two HBS, made of AZ31 
and ZM21 alloy respectively, was proposed. A new stent concept (Fig. 3 left) was developed with the help of a 
classical topology optimization procedure [10]. The design has five rings connected by curved links, presenting six 
A 
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peak-to-valley struts in the circular direction. The dimensions of the outer diameter (1.4 mm) and thickness (0.15 mm) 
were arbitrarily fixed equal to those of an existing Mg alloy stent. A shape optimization procedure was applied to the two-
dimensional (2D) model of the new design concept to minimize stress and strain after stent deployment and to improve 
scaffolding ability. Considering the fact that in an optimization process requires to run many analyses, the use of a 2D 
model is extremely beneficial, allowing to save lots of simulation time. Moreover, it is recognized in the literature that a 
2D stent model can well represent the corresponding 3D model [11,12] and in this case it was verified that differences in 
the results (e.g. strain) between 2D and 3D expansion simulations were acceptable (less than 10%). Only one strut unit 
(Fig. 3 right) was chosen for optimization owing to the highly symmetrical design. A morphing procedure was used to 
change the strut unit shape: a few nodes at the edges of a domain (all the elements) were set as handles to control the 
change of the shape. An optimization algorithm based on the adaptive response surface method [13] was applied to 
control the shape evolution. During the procedure finite element (FE) analyses were performed on two 2D models (same 
design but different materials) transferred from the parametric CAD: a vertical displacement was applied to the end of the 
curved part of the strut to simulate the expansion of the three-dimensional (3D) stent model to an outer diameter of 3.0 
mm. 
The two main optimization objectives for a magnesium alloy stent are minimizing maximum principal strain, to avoid 
fracture, and maximizing mass or strut width, to extend the corrosion time and provide adequate scaffolding. However 
they are contradictory because more material may increase the strain during expansion. Accordingly, a two-step strategy 
was applied to find a proper design comprising the main objectives. First, only the maximum strain was minimized. In 
particular a solution was found when the maximum principal strain was below the 80% of the fracture strain. Second, the 
design with maximum normalized mass was chosen as an optimized design from optimization iterations whose maximum 
principal strains were below the fixed limit. The optimized design is pictured in Fig. 3. For more details about the 
optimization process refer to [14].  
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Figure 2: On the left: Tensile curves of the selected magnesium alloys. On the right: mass loss (ML) versus time curves of the studied 
alloys obtained from immersion tests and corresponding ML values and optical images of the specimens observed after 90h. 
 
 
Figure 3: On the left: CAD model of the new conceptive stent in the original configuration In the box is indicated the one strut unit 
chosen for the optimization. On the upper right: 2D dimensions of the new conceptive stent. In red the strut unit for optimization. 
The unit is composed of curved (Cu), straight (St), and solidus (So) parts. On the lower right: optimized vs original design for ZM21 
alloy stent.   
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For a preliminary validation of the obtained results, 2D magnesium specimens having the geometry of the original and 
optimized models were manufactured by laser cut and experimentally tested for fracture. The original design broke at the 
lower displacement than the optimized design and in the locations corresponding to stress concentrated area in the 
simulations, showing that the optimized design was safer than the original one during expansion (Fig. 4). 
 
 
 
Figure 4: Comparison of the two 2D samples after fracture test: the original design (left) ruptured at lower elongation than the 
optimized one (right).  
 
 
A DAMAGE MODEL FOR DESCRIBING STENT DEGRADATION 
 
iming to develop a methodology that allows to select among different geometries the most suitable in terms of 
corrosion with a limited use of experimental tests, a numerical model was developed into the frame of continuum 
damage approach. Accordingly, a corrosion damage parameter is introduced to reflect in a phenomenological way 
the reduction of mechanical properties of materials. Two corrosion mechanisms are considered to attack the material in a 
cooperative way: uniform corrosion damage DU, which accounts for the mass loss when exposed to a corrosive 
environment [15]; and stress corrosion damage DSC, which describes the localized corrosion attacks in areas of the 
material where the stress is more concentrated [16]. The global corrosion damage variable (D) is assumed to be a linear 
superposition of the two mechanisms. A value of D of 0 means that the element is intact; when D equals 0.9, the element 
is completely damaged and will be deleted from the model during the simulation.  
The damage evolution law for uniformly distributed corrosion is: 
 
U
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L
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
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
  
 
where the notation dotted DU represents the time derivative, kU is a parameter related to the kinetics of the process and U 
is a characteristic dimension of the uniform corrosion process (e.g. the critical thickness of the corrosion film).  
The damage evolution law for stress corrosion is [17]: 
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where 

eq is an equivalent stress governing the stress corrosion mechanism: in this model the maximum principal stress is 
adopted assuming that the corrosion rate is higher at tensile stressed regions. th corresponds to the equivalent stress value 
below which the stress corrosion process does not occur: in this model th is assumed equal to 50% of the yield stress 
[18]. S and R are constants related to the kinetics and SC is a characteristic dimension of the stress corrosion process. 
For a proper reduction of mesh sensitivity phenomena, a direct dependency of damage evolution on the characteristic FE 
length Le has been assumed. In particular, the ratio Le/δ has been adopted in the evolution law to scale the numerical grid 
characteristic length over a relevant characteristic dimension of the corrosion process. See [19] for a detailed description 
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of the model and the used parameters. The model was implemented into a FE framework using the commercial code 
ABAQUS/Explicit (Dassault Systemes Simulia Corp., RI, USA) by means of a user subroutine (VUSDFLD) devoted to 
calculation of the damage increment through the evolution law affecting the updated stress state in the explicit time 
integration scheme. It was used to compare the corrosion behavior of the optimized stent (OPT) and of a patented stent 
(PAT) from Institute of Metal Research, CAS, Shenyang, China [20], both based on the magnesium alloy AZ31. To 
reduce the simulation time, we took advantage of the geometrical repetition of stent designs and we built the 3D FE 
models of only one ring of the two designs (Fig. 5). Aiming to study the stent degradation process taking into account the 
stress distribution due to implantation, we simulate all the steps of the procedure: stent crimping, balloon expansion, 
balloon deflating and stent recoil, stent-vessel interaction. Finally the degradation process was simulated. The details of the 
FE analyses are reported in [21]. It was observed that the element deletion occurred first at simulated locations of 
concentrated high stresses for both the designs: assumed the relative time t* equal to 1 when both the stents lacked their 
structural integrity, the stress corrosion started at t* equals 0.19, while the uniform corrosion evolved at the outer surfaces 
throughout the whole degradation process. PAT had a fast stress corrosion concentrated near the bows: when t* equals 
0.57, the structure was severely damaged and lost its structural integrity at t* equal to 0.7. OPT kept more uniform stress 
corrosion: at t* equals 0.95, all elements at the original outer surface were deleted and some locations were severely 
damaged; however, the stent still conserved its structural integrity. 
To verify the FE analysis results, an experimental test was performed. The details are presented in [22]. For each design, 
six stent samples were manufactured by laser cut of AZ31 tubes. After stent crimping and expansion, all the 12 samples 
were immersed in DHanks’ solution to test for degradation according to ISO 11845:1995. It was verified that under the 
same degradation conditions, the OPT samples keep the structural integrity longer than the PAT samples and that the 
degradation of the stent samples effectively includes uniform and stress corrosion. The model was able to predict the 
locations of sample fractures, corresponding to the locations with high residual stress. In Fig. 6 two broken samples and 
the corresponding simulation results are shown. 
 
 
 
Figure 5: One ring 3D FE models of the optimized stent (left) and the patented stent (right) used in the degradation process 
simulations.  
 
 
 
Figure 6: Experimental and numerical results of the corrosion tests of the optimized stent (left) and the patented stent (right). 
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ALLOY OPTIMIZATION AND TUBE PRODUCTION 
 
nce the magnesium alloys were selected after considerations about mechanical, corrosion and toxicity 
properties, an optimization of the manufacturing process was performed to control microstructure and final 
properties of the material after production of the mini-tube by hot deformation and cold drawing, laser cutting 
and chemical etching of the net for the stent.  
After a detailed analysis of the texture effects on design of BRS [23], we aimed to obtain a bulk ultrafine-grained (UFG) 
alloy on order to be able to exploit its enhanced properties: i) improved strength by marked reduction of grain size; ii) 
improved formability by possible superplastic properties; iii) improved mechanical behavior by modification of texture 
and removal of basal texture; iv) improved corrosion resistance by break-up of second-phase particles and a more 
homogeneous microstructure. Moreover in miniaturized devices, the specific orientation of single grains facing 
geometrical stress raisers leads to uncontrolled variability of device strength. On the contrary, finer grains on the cross 
section of the strut are expected to give a more homogeneous mechanical performance and reduce the random 
orientation effect given by coarse crystals. 
Among the several methods based on severe plastic deformation that can be used to achieve an UFG structure in metals, 
the equal channel angular pressing (ECAP) was selected having the advantage of producing billets with size compatible 
for further extrusion of mini-tubes for stent manufacturing. After some studies, it was defined as optimal strategy for 
ECAP a preliminary processing at 200-250°C and then further refinement at 150-100°C. As an example, for ZM21 alloy 8 
passes at 200°C 8 passes at 150°C were selected and allowed to pass from an average grain size of 15 mm for annealed 
material to a size of 0.52 mm after ECAP at 150°C (Fig. 7 left).  
To produce stent precursors, an ad hoc set-up was developed. Extrusion was performed at 150°C, at relatively low strain 
rate of 3×10-3s-1 maintaining ultra fine grain structure. As final products, tubes having a diameter of 2.5 mm and wall 
thickness of about 0.2 mm were obtained (Fig. 7 right). 
 
 
 
Figure 7: On the left: UFG of ZM21 alloy after ECAP; on the right: stent precursors 
 
 
THE STENT PRODUCTION 
 
he mesh of the OPT stent was cut on AZ31 tubes extruded as described above with an active fiber laser operating 
in ns pulse regime with 50 W maximum average power (IPG- YLP-1/100/50/50). In Tab. 1 the main 
characteristics of the laser source are reported. A cutting head (LaserMech) that housed a 60 mm focusing lens 
and a nozzle for process gas addition was used with the laser source. The calculated beam diameter in this configuration 
was 23 µm, which allowed microcutting with small kerf widths. The positioning system consisted of a linear and a rotary 
axis (Aerotech ALS and ACS series) with nanometric resolution. Laser cutting was applied with 7.5 W average power, 25 
kHz of pulse repetition rate and argon as assist gas with 7 bar pressure (purity 99.998%), and cutting speed of 2 mm/s was 
employed. Chemical etching with an acidic solution of HNO3 (65% purity) 10 mL, ethanol 90 mL was preferred to 
remove dross and to clean the kerf. The chemical operation was employed to complete separation of the stent mesh from 
the scrap pieces as well as to provide strut polishing [24]. The AZ31 stent after chemical etching is reported in Fig. 8. It 
can be seen that the stent surface is clearly free of defects. The mesh design has been reproduced with high precision on 
the tube. However, the stent walls show high roughness compared to the stent surfaces, which implies that further 
chemical polishing is required. The high corrosion rate of AZ31 in the chemical etching solution may cause excessive 
O 
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etching of the stent body resulting in deviations from the stent geometry. The laser cutting quality consequently changes 
the final quality of the stent mesh after chemical etching. Through a comparative analysis the use of fs pulsed laser has 
showed an excellent compromise between surface quality after laser cutting and ease of dross reduction with chemical 
etching [25]. Although, today they are not highly diffused, the use of ultra-fast lasers in the industry is expected to increase 
in future if the capital and operational costs are reduced. 
 
 
 
Figure 8: Optical microscopy image of the AZ31 after chemical etching. 
 
IPG YLP-1/100/50/50 Q- switched laser  
Laser wavelength  1064 nm 
Maximum average power  50 W 
Maximum pulse energy  1 mJ 
Minimum pulse duration [FWHM] 100 ns 
Pulse repetition rate  20-80 kHz 
Beam quality factor (M2) 1.7 
Focused laser beam diameter  23 µm 
High precision positioning system   
Spindle accuracy  ±72.7 µrad
Linear axis accuracy  1 µm 
 
 
Table 1: Main specifications of the laser source for stent cutting. 
 
 
COATING SELECTION AND ADHESION STUDY  
 
mong polymers commonly employed for stent coatings, such as polylactide (PLA), polycaprolactone (PCL) and 
polyglycolide (PGA), we investigated the potentialities of PCL for HBS production. A rotating confined dip 
coater was developed. Different experimental tests were performed to optimize the coating procedure of PCL on 
small plates in AZ31 alloy. Different speeds of immersion and extraction of the plates, different number of layers and 
different concentrations of PCL dissolved in chloroform or dioxane and tetrahydrofuran (THF) 1:2 ratio, were 
considered. Finally a concentration of PCL in chloroform equal to 1,5% w/v, a rotation speed of 300 rpm and a 
withdrawal speed of 150 mm/min were selected, obtaining a smooth substrate with values of thickness ranging between 5 
and 10 µm.  
Previous studies revealed that peeling phenomenon (or coating delamination) sometimes occurs for coated stainless stents 
during stent expansion [26]. If this happens to HBS, it will lead to premature corrosion onset: indeed, the corrosion will 
concentrate at the unprotected location and the attack will accelerate the damage of the structure. Aiming to set up a 
methodology that allows to select among different coatings the most suitable one in terms of adhesion properties with a 
limited use of experimental tests, the numerical tools available in the literature to analyze crack initiation and propagation 
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of surface-bonded structures were investigated. In particular FE simulations of the expansion of the HBS were performed 
exploiting the cohesive zone method [27] implemented in the commercial code ABAQUS. 
Among the broad set of cohesive element features offered by ABAQUS, in this study, a triangle traction-separation law 
was chosen. Under traction deformation, the cohesive element will resist the separation between the connected surfaces 
with a linearly increased traction stress (along nominal stiffness Keff). When the traction stress reaches the maximum limit 
Tult (with the separation distance 0), the damage occurs and the traction stress decreases with further separation. At the 
same time, a scalar damage variable Dc, which records the damage of the cohesive element, increases starting from 0. 
When the element finally fails with separation f, the traction stress reduces to 0 and Dc accumulates to 1. The area under 
the curve represents the critical energy release rate Gc. 
To calibrate the cohesive element method and to measure Gc, peeling experiments were carried out for the PCL coating 
on the magnesium plates. The PCL was dissolved in chloroform at a concentration of 5% w/v and was dropped onto 
AZ31 foils (70mm x 4mm x0.8mm). Samples were left under a hood for 24 hours to allow the complete solvent 
evaporation and a uniform PCL coating with a thickness of 0.01 mm was obtained. A 90-degree peeling test was carried 
out by a MTS Synergie 200H testing machine (MTS Systems Corporation, Minneapolis, MN,USA). Three samples were 
tested.  
Gc was evaluated through experimental results using the formula below [28]: 
 
    




 

cos 1
b
F
hE 2
1
b
F
G
2
c  
 
where  and F are the angle and force of peeling, b is the width, h the thickness and E the Young modulus of the coating. 
The FE model used to simulate the peeling tests is reproduced in Fig. 9 (left). According to the penalty parameter method 
proposed in [29], known Gc, other model parameters were obtained once defined f. A sensitivity analysis was performed 
varying the value of f and of the mesh-relative cohesive ductility ratio, f/L, being L the characteristic length of the 
mesh. The same mesh density was used for the cohesive elements (2-dimensional, 4 node, cohesive element type 
COH2D4) as for the coating elements (2-dimensional, 4 node, element type CPE4R), as shown in Fig. 9 (right). The 
quantity selected for comparing different meshes were the adhesion force, in terms of mean value (compared with the 
experimental results) and the oscillation around this value (noisy solution due to “zipper effect”[29]). After these analyses, 
an average mesh length (mesh density) of 0.0075 mm and a key penalty parameter δf of 0.008 mm were selected, showing 
a good match with the experimental data and independency of the numerical results from the mesh size (result difference 
less than 2% compared to denser meshes). 
 
   
 
Figure 9: Finite element model of the peeling test (left); detail of the FE analysis mesh and results. 
 
Once the method and the parameters were calibrated, the model was used to study the coated stent. The 2D strut model 
of OPT design with a polymer coating was modeled by finite elements. Just one side of the coating was studied because of 
the symmetry of the location. The thickness of the coating and of the cohesive layer was 0.01 mm and 0 mm, respectively. 
A symmetrical boundary condition in Y-direction was applied to one strut end and a displacement in Y-direction was 
applied to the other end to simulate stent diameter expansion from 2 mm to 3 mm. The mesh had a very similar element 
density and the same cohesive element properties as the peeling testing model (Fig. 10). 
The cohesive elements were stretched after expansion, and finally failed in the inner bow of the strut when the scalar 
damage variable Dc of these cohesive elements reached 1 (Fig. 11 left and center). The analyses were repeated with 
different thickness values of the coating with the same results.  
To validate the computational analysis results, stent-like 2D specimens were laser cut, subjected to chemical etching and 
coated by PCL, using the same technique as plate samples. The coated specimens were stretched using the same tensile  
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machine used for peeling tests. Peeling was detected in the bow structure of the stent strut, coherently with the simulation 
prediction (Fig. 11 right).   
The failure of the coating was probably due to the very low adhesion force of the polymer. Accordingly some solutions 
are currently under evaluation: change of the polymer (PLLA), treatment of the stent surface to increase roughness, 
substitution of the dipping coating technique with spraying technique.  
 
 
         
 
Figure 10: 3D one ring model of OPT (left) and 2D coated OPT stent strut model. 
 
 
301
0
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0
 
 
Figure 11: Numerical and experimental results of the expansion of the coated OPT stent design. Left: Von Mises stress distribution of 
the stent strut in MPa. Center: scalar damage variable Dc of the cohesive layer. Right: damaged coating after stent-like 2D specimen 
expansion. 
 
 
CONCLUSIONS 
 
 multidisciplinary approach was used to create a hybrid stent, made of magnesium alloy and coated by polymer. 
With the effective contribution of FE method, the development of stent has been gained in stent structure 
design, corrosion analysis, and coating peeling prediction. The compatible results between simulations and 
experiment verifications indicate that FE method is a powerful tool for magnesium stent evolution. More applications of 
FE method in magnesium stents are under way and the combination of simulation and experiment will be a development 
standard in the future. 
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